A potential world-changing test developed in Queensland is set to be trialled among 1500 women in the hopes it can be come a general screening tool for deadly ovarian cancer.

A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

Participants will be given a pathology request form and can have the blood test done at a convenient collection centre or at ...

Add Yahoo as a preferred source to see more of our stories on Google. Ovarian cancer is usually diagnosed using a mix of scans and blood tests (Getty/iStock) A straightforward blood test shows promise ...

If you have recurrent or platinum-resistant ovarian cancer, your doctor may recommend folate receptor alpha (FRα) testing. If you test positive for elevated levels of FRα (expressed on 75 percent or ...

Only 23.3% of ovarian cancer patients receive BRCA testing, leading to higher treatment costs and advanced therapy lines. Non-White and low-income patients face increased financial toxicity, ...

Women with an inherited risk of developing ovarian cancer because they have the so-called Angelina Jolie gene alteration can now be tested on the NHS thanks to UCL research. University College London ...

Multigene NGS on tumor tissue accurately identifies pathogenic variants in EOC, supporting a tumor-first genetic testing model. The study found 94.3% of tumors had detectable variants, with 99.1% ...

June 14, 2010 — The US Food and Drug Administration (FDA) has cleared a chemiluminescent microparticle immunoassay (Architect human epididymis protein 4 [HE4] assay; Abbott Diagnostics) for the ...